Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Human Papillomavirus Infection as a Prognostic Factor in Oropharyngeal Squamous Cell Carcinomas Treated in a Prospective Phase II Clinical Trial

SOLOMON JO, AGNES JUHASZ, KEQIANG ZHANG, CHRISTOPHER RUEL, SOFIA LOERA, SHARON P. WILCZYNSKI, YUN YEN, XIYONG LIU, JOSHUA ELLENHORN, DEAN LIM, BENJAMIN PAZ, GEORGE SOMLO, NAYANA VORA and STEPHEN SHIBATA
Anticancer Research May 2009, 29 (5) 1467-1474;
SOLOMON JO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AGNES JUHASZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEQIANG ZHANG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTOPHER RUEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOFIA LOERA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHARON P. WILCZYNSKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUN YEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
XIYONG LIU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOSHUA ELLENHORN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DEAN LIM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BENJAMIN PAZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEORGE SOMLO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NAYANA VORA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHEN SHIBATA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sshibata{at}coh.org
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Kaplan-Meier survival curves for progression-free and overall survival with respect to HPV status.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Scatter plots for the ratio of VEGF (A) and HIF-1α (B) mRNA expression levels to β-actin (housekeeping gene) by quantitative RT-PCR; (C) comparison table of the levels of VEGF and HIF-1α mRNA transcript by HPV status.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
  • Table IV.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 29, Issue 5
May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
  • Back Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Human Papillomavirus Infection as a Prognostic Factor in Oropharyngeal Squamous Cell Carcinomas Treated in a Prospective Phase II Clinical Trial
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Human Papillomavirus Infection as a Prognostic Factor in Oropharyngeal Squamous Cell Carcinomas Treated in a Prospective Phase II Clinical Trial
SOLOMON JO, AGNES JUHASZ, KEQIANG ZHANG, CHRISTOPHER RUEL, SOFIA LOERA, SHARON P. WILCZYNSKI, YUN YEN, XIYONG LIU, JOSHUA ELLENHORN, DEAN LIM, BENJAMIN PAZ, GEORGE SOMLO, NAYANA VORA, STEPHEN SHIBATA
Anticancer Research May 2009, 29 (5) 1467-1474;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Human Papillomavirus Infection as a Prognostic Factor in Oropharyngeal Squamous Cell Carcinomas Treated in a Prospective Phase II Clinical Trial
SOLOMON JO, AGNES JUHASZ, KEQIANG ZHANG, CHRISTOPHER RUEL, SOFIA LOERA, SHARON P. WILCZYNSKI, YUN YEN, XIYONG LIU, JOSHUA ELLENHORN, DEAN LIM, BENJAMIN PAZ, GEORGE SOMLO, NAYANA VORA, STEPHEN SHIBATA
Anticancer Research May 2009, 29 (5) 1467-1474;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Integrated analysis links TP53, NOTCH, SLC38A and 11p with survival in patients with oral tongue squamous cell carcinoma
  • Google Scholar

More in this TOC Section

  • Real-world Delivery and Outcomes of Intravesical BCG for Non–muscle-invasive Bladder Cancer
  • Early Progressive Disease Predicts Poor Outcomes of Second-line VEGFR Tyrosine Kinase Inhibitor Therapy After First-line Nivolumab Plus Ipilimumab in Advanced Renal Cell Carcinoma
  • Evaluation of Quality Metrics for Dose Assessment in Field Overlap Regions of VMAT-Based Craniospinal Axis Irradiation
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire